Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
advances in neurology
adverse drug reaction
anesthesia, epidural
anesthesia, spinal
azathioprine
B cell lymphocytes
BENEFIT study
bladder dysfunction
blood brain barrier
breast feeding
carcinoma
carcinoma of breast
children
chills
compliance
complications
controversies in neurology
cop 1
cost effectiveness
cotton-wool spots
cyclophosphamide
cyclosporine
cytokines
depression
disability rating scale, neurological
disability, neurological
efficacy
emotional lability
evidence-based research
facial weakness
fatigue
fetus
fever
flu-like illness
fundus, abnormality of
gadolinium
gammaglobulin therapy, intravenous
genetic neurologic disorders
headache
hepatic failure
hepatitis
herpes simplex virus
herpes virus
herpes virus infection
HLA
human herpesvirus 6
iatrogenic neurologic disorders
ibuprofen
immunomodulation
immunosuppressive agents
infection
interferon
interferon alpha
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon gamma
interleukin 6
intrauterine
leukopenia
liver disease
liver function enzymes
lymphopenia
menses
menses, irregular
methotrexate
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, lesion burden
MRI, serial
MRI, volumetry
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, prognosis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle pain
natalizumab
neuropathology
neuropathy
neuropathy, medication induced
neutralizing antibodies
neutralizing antibodies, cross-reactive
neutropenia
nonsteroidal anti-inflammatory drug
ocrelizumab
oxybutynin
patient information and support
pentoxifylline
plasmapheresis
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
quality of life
research
retinopathy
review article
safety
serum alanine aminotransferase
serum glutamic oxaloacetic transaminase
skin, lesions in neurologic disorders
spasticity
steroid
steroid therapy, CNS treatment and complications with
treatment of neurologic disorder
tumor necrosis factor
tumor necrosis factor inhibitor
viral infection, reactivation
weakness
Showing articles 100 to 150 of 1929 << Previous Next >>

Intramuscular Interferon Beta-1a Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis
NEJM 343:898-904, Jacobs,L.D. et al, 2000

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Severe Anaphylaxis with Recombinant Interferon Beta
Neurol 52:425, Corona,T.,et al, 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Effect of Steroids on Gd-Enhancing Lesions Before & During Beta Interferon 1a Trtm in Relapsing Remitting MS
Neurol 50:403-406, Gasperini,C.,et al, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022

Toward Simpler, Safer Treatment of Cryptococcal Meningitis
NEJM 386:1179-1181, Moosa, M.Y.S. & Lessells, R.J., 2022

Cerebral Microbleeds
Neurol 92:e253-e262, Graff-Radford, J.,et al, 2019

Numb Chin Syndrome
UptoDate.com Sept, Robertson, C.E., 2018

Presentation of Diffuse Large B-Cell Lymphoma with Bilateral Sequential Oculomotor Neuropathy
Neurol 91;e92-e93, Galla, K.M.,et al, 2018

Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018

Candida Meningitis in an Immunocompetent Patient Detected Through (1?3)-beta-?-glucan
Int J Infect Dis 51:25-26, Farrugia, M.K.,et al, 2016

Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015

Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA 313:1939-1949,1913, Ossenkoppele, R.,et al, 2015

Infections of the Nervous System, (Bacterial, Fungal, Spirochetal, Parasitic) and Sarcoidosis, Cryptococcosis (Torulosis European-Blastomycosis.
Adams & Victors Principles of Neurology, Chp 32, pg 731, Ropper, A.H.,et al, 2014

Intracranial Neoplasms and Paraneoplastic Disorders, Primary Central Nervous System Lymphoma
Adams & Victors Principles of Neurology, Chp 31, pg 658, Ropper, A.H.,et al, 2014

Degenerative Diseases of the Nervous System, Alzheimer Disease
Adams & Victors Principles of Neurology, Chp 39, pg 1063, Ropper, A.H.,et al, 2014

Nocardiosis of the Central Nervous System
Medicine 93:19-32, Anagnostou, T.,et al, 2014

Predicting Alzheimer Disease with �-Amyloid Imaging: Results from the Australian Imaging, Biomarkers, and Lifestyle Study of Ageing
Ann Neurol 74:905-913, Rowe, C.C.,et al, 2013

Combination Antifungal Therapy for Cryptococcal Meningitis
NEJM 368:1291-1302, Day, J.,et al, 2013

PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013

Clinical and Biomarker Changes in Dominantly Inherited Alzheimers Disease
NEJM 367:795-804,864, Bateman, R.J.,et al, 2012

Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection
NEJM 367:885-887, Yang, L.,et al, 2012

Predicting sites of New Hemorrhage with Amyloid Imaging in Cerebral Amyloid Angiopathy
Neurol 79:320-326, Gurol, M.E.,et al, 2012

Subjective Cognition and Amyloid Deposition Imaging
Arch Neurol 69:223-229, Perrotin,A.,et al, 2012

A 21-year old Woman with Multiple Cancers and a New Brain Lesion
Neurol 78:743-749, Schiff,D.,et al, 2012

Is It All Cerebral Toxoplasmosis?
Lancet 379:286, Mentzer,A.,et al, 2012

Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011

Cerebral microhemorrhage and brain B-amyloid in aging and Alzheimer disease
Neurol 77:48-54, Yates, P.A.,et al, 2011

Longitudinal Assessment of A-beta and Cognition in Aging and Alzheimer Disease
Ann Neurol 69:181-192, Villemagne,V.L.,et al, 2011

AIDS - Related Lymphomas: Primary CNS Lymphoma
UpToDate, April, Doweiko, J.P., 2010

C-PIB Binding is Increased in Patients with Cerebral Amyloid Angiopathy-related Hemorrhage
Neurol 74:487-493, Ly,J.V.,et al, 2010

AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010

Small Fiber Neuropathy: A Burning Problem
Cleve Clin J Med 76:297-305, Tavee, J. & Zhou, L., 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Plasmablastic Lymphoma: CNS Involvement, Coexistence of Other Malignancies, Possible Viral Etiology, and Dismal Outcome
Ann Hematol 88:351-358, Ustun, C.,et al, 2009

Primary Central Nervous System Plasmablastic Lymphoma in AIDS
Neuropath Appl Neurobiol 34:245-247, Shuangshoti, S.,et al, 2008

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008

Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008

Assessment of �-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography with Carbon 11-Labeled Pittsburgh Compound B
Arch Neurol 65:1304-1309,1281, Leinonen,V.,et al, 2008

Imaging of Amyloid Burden and Distribution in Cerebral Amyloid Angiopathy
Ann Neurol 62:229-234, Johnson,K.A.,et al, 2007

Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating Between Intracranial Malignancy and Infection in AIDS Patients
AJNR 26:1973-1979, Younhg,R.J.,et al, 2005

Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005

CT and MRI Findings of Intracranial Lymphoma
AJR 184:1679-1685, Slone,H.W.,et al, 2005

Differentiation of Toxoplasmosis and Lymphoma in AIDS Patients by Using Apparent Diffusion Coefficients
AJNR 24:633-637,554, Camacho,D.L.A.,et al, 2003



Showing articles 100 to 150 of 1929 << Previous Next >>